White Willow Bark: Benefits, Dosage, Forms & Research

What the Research Says

White willow bark has been used for pain relief for over 3,500 years and was the inspiration for aspirin development in the 1890s. The key clinical trial by Chrubasik et al. (2000, n=210) found 240mg salicin daily superior to placebo for acute low back pain, with a separate trial showing comparable efficacy to rofecoxib. Schmid et al. (2001, n=78) confirmed benefit for hip/knee OA. Notably, willow bark appears gentler on the stomach than aspirin because salicin is converted to salicylic acid after intestinal absorption, bypassing direct gastric irritation. However, it should still be avoided in aspirin-sensitive individuals. The presence of additional polyphenols may explain why willow bark has broader anti-inflammatory effects than the equivalent salicin dose alone would predict.

Benefits of White Willow Bark

• Lower back pain — Chrubasik et al. (2000, n=210) found 240mg salicin daily reduced pain scores significantly more than placebo, with efficacy comparable to rofecoxib 12.5mg
• Osteoarthritis — Schmid et al. (2001, n=78) demonstrated willow bark extract (240mg salicin) significantly reduced WOMAC pain scores in hip and knee OA patients over 2 weeks
• COX-2 inhibition — salicylic acid (from salicin metabolism) inhibits COX-2 enzyme activity and expression, reducing prostaglandin E2 production
• GI-sparing mechanism — salicin is not directly irritating to gastric mucosa; it is converted to salicylic acid after absorption, potentially causing less GI damage than aspirin
• Synergistic polyphenols — willow bark contains flavonoids, tannins, and other polyphenols that provide antioxidant and anti-inflammatory effects beyond salicin alone

Side Effects and Safety

Safety profile: Safe with Caution

Potential Side Effects

• GI discomfort (nausea, stomach pain) — less common than with aspirin
• Allergic reaction in aspirin-sensitive individuals — CONTRAINDICATED in aspirin allergy
• Not recommended for children under 16 due to theoretical Reye's syndrome risk
• May cause dizziness or drowsiness (rare)

Drug & Supplement Interactions

• Aspirin and NSAIDs — do not combine; additive effects increase bleeding and GI risk
• Anticoagulants (warfarin) — salicylates may increase bleeding risk; monitor INR
• Methotrexate — salicylates can reduce renal clearance of methotrexate, increasing toxicity risk
• Phenytoin, valproic acid — salicylates may displace these from protein binding, increasing free drug levels